Login / Signup

[Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of the drug riamilovir for the prevention of COVID-19].

A U SabitovDmitriy A LioznovK V ZhdanovE P TihonovaE V EsaulenkoP V Sorokin
Published in: Terapevticheskii arkhiv (2024)
).
Keyphrases
  • double blind
  • clinical trial
  • coronavirus disease
  • placebo controlled
  • sars cov
  • phase ii
  • phase iii
  • study protocol
  • respiratory syndrome coronavirus
  • adverse drug
  • emergency department
  • electronic health record